PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

darifenacin vs trospium

Side-by-side comparison of darifenacin and trospium Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
darifenacin Anticholinergic (Overactive Bladder)
trospium Anticholinergic (Overactive Bladder)
Type
darifenacin Prescription
trospium Prescription
Summary
darifenacin

Darifenacin (Enablex) is a medicine that helps control an overactive bladder. It reduces the feeling of needing to go to the bathroom so often.

trospium

Trospium chloride (Sanctura) helps control an overactive bladder. It reduces the feeling of needing to go to the bathroom often.

What It Treats
darifenacin

This medicine treats overactive bladder. If you have overactive bladder, you may feel a sudden need to urinate. You may also urinate more often than normal, or leak urine.

trospium

This medicine treats overactive bladder (OAB). OAB can cause a frequent and urgent need to urinate. It can also cause urge urinary incontinence, which is leaking urine when you feel a sudden need to go.

How It Works
darifenacin

Darifenacin blocks certain receptors in the bladder. These receptors cause the bladder muscles to contract. By blocking them, the medicine helps the bladder relax and hold more urine.

trospium

Trospium chloride blocks the action of a chemical called acetylcholine. This chemical can cause bladder muscles to squeeze too much. By blocking acetylcholine, the medicine helps the bladder relax, reducing the urge to urinate.

Common Side Effects
darifenacin
  • Dry mouth
  • Constipation
  • Headache
  • Upset stomach
  • Nausea
trospium
  • Dry mouth
  • Constipation
  • Headache
FAERS Reports
darifenacin
  • The medicine is not working 99
  • Swelling in the hands, feet, or ankles 91
  • Shingles 83
  • Viral pneumonia 79
  • Low red blood cell count 59
trospium

No adverse event reports.

Serious Warnings
darifenacin

If you have bladder problems that cause you to have trouble urinating, use darifenacin with caution because it could make it harder to urinate. Use caution if you have stomach or bowel blockage, as this medicine can make it worse. Darifenacin may cause sleepiness, so do not drive or operate heavy machinery until you know how it affects you. Angioedema (swelling of the face, lips, tongue, and/or throat) has been reported with darifenacin and can be life-threatening.

trospium

Trospium chloride should be used carefully if you have a bladder blockage or stomach problems, as it can cause you to not be able to urinate or have gastric retention. This medicine may cause swelling of the face, lips, tongue, or throat, which can be life-threatening. Get medical help right away if this happens. Trospium may cause sleepiness, so be careful driving or using machines until you know how it affects you.

Pregnancy
darifenacin

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if darifenacin will harm your unborn baby. Talk to your doctor if you are breastfeeding or plan to breastfeed, as it is not known if darifenacin passes into breast milk.

trospium

Tell your doctor if you are pregnant or plan to become pregnant. This medicine should only be used during pregnancy if clearly needed. It is not known if this medicine passes into breast milk, so talk to your doctor if you are breastfeeding.

Also Compare — Nearby Drugs

How to Read This darifenacin vs trospium Comparison

darifenacin is classified in the Anticholinergic (Overactive Bladder) drug class, while trospium sits within the Anticholinergic (Overactive Bladder) class. Because both drugs share the same classification, they are often considered interchangeable in theory — but clinical outcomes rarely track that cleanly. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, darifenacin has 411 submissions while trospium has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between darifenacin and trospium — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.